Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases—systemic sclerosis and sclerodermatous graft-versus-host disease

Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases—systemic sclerosis and sclerodermatous graft-versus-host disease

Abstract Background Systemic sclerosis (SSc) and sclerodermatous graft-versus-host disease (Scl-GVHD)—characterized by similar developmental fibrosis, vascular abnormalities, and innate and adaptive immune response, resulting in severe skin fibrosis at the late stage—are chronic autoimmune diseases...

Full description

Bibliographic Details
Main Authors: Han Yang, Sousan Cheong, Yunfan He, Feng Lu
Format: Article
Language:English
Published: BMC 2023-12-01
Series:Stem Cell Research & Therapy
Subjects:
Mesenchymal stem cells
Autoimmune-related fibrotic skin diseases
Systemic sclerosis
Sclerodermatous graft-versus-host disease
Chronic graft-versus-host disease
MSC-based therapy
Online Access:https://doi.org/10.1186/s13287-023-03543-w

Internet

https://doi.org/10.1186/s13287-023-03543-w

Similar Items